secwatch.observer — SEC 8-K summary
======================================

Issuer:     MCKESSON CORP (MCK)
CIK:        0000927653
Form:       8-K
Filed at:   2025-05-08T23:59:59+00:00
Accession:  0000927653-25-000034
Event type: earnings
Sentiment:  positive
Materiality: 0.90
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

McKesson Q4 revs $90.8B (+19%), adj. EPS $10.12 (+64%); guides FY26 adj. EPS $36.75-37.55; plans Med-Surg spin-off
--------------------------------------------------------------------------------

- Q4 consolidated revenues $90.8B (+19% YoY); GAAP diluted EPS $10.01; adjusted diluted EPS $10.12 (+64%).
- Full-year FY25 revenues $359.1B (+16%); adjusted EPS $33.05 (+20%); cash flow from ops $6.1B, FCF $5.2B.
- FY26 adjusted EPS guidance $36.75-$37.55 (11-14% growth); reaffirms long-term adj. EPS growth target 12-14%.
- Announces intention to separate Medical-Surgical Solutions into independent company to unlock shareholder value.
- U.S. Pharmaceutical long-term segment profit growth target raised from 5-7% to 6-8%.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/927653/000092765325000034/0000927653-25-000034-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/927653/000092765325000034/mck-20250508.htm
  HTML page:      https://secwatch.observer/filing/0000927653-25-000034

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer